This summer, Mission: Cure is excited to welcome nine incredible interns to our team. As our largest summer intern cohort ever, they have been busy in these past few weeks learning about chronic pancreatitis and Mission: Cure’s model and speaking with other individuals in Mission: Cure’s network. Despite not being able to be physically together, […]

We at Mission: Cure are shocked and outraged by the circumstances surrounding the deaths of George Floyd, Breonna Taylor, Tony McDade, Sandra Bland, Ahmaud Arbery and countless other victims of anti-Black violence. We stand in solidarity with the Black community, the Black Lives Matter movement, and efforts to end systemic racism. We commit to addressing

Mission: Cure believes that new innovations in medical research are key to achieving our goal of curing chronic pancreatitis. For this reason, we strive to leverage and support advances in genomics and precision medicine and aim to collaborate with forward-thinking and mission-driven organizations. Today, we are excited to announce our partnership with Perlara, a rare disease

Mission: Cure aims to demonstrate a new model for curing disease, leveraging outcome-based financing and impact investing. Our first mission is to find a cure for CHRONIC PANCREATITIS, a painful and disabling disease that affects 150,000 people, including 10,000 children. Our goal is to accelerate the development of promising new treatments and find a cure.

“Mission: Cure” Launched to Harness Innovative Financing and Impact Investing to Cure Disease; Pioneers New Approach by Attacking Pancreatic Disease New York, New York, Tuesday, November 7, 2017—The new nonprofit Mission: Cure will convene the world’s leading pancreatic experts at the American Pancreatic Association meeting in San Diego on November 10th to devise a 10-year